Financial Statements and Related Announcement::First Quarter Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
14-Aug-2021 00:28:07
Status
New
Announcement Sub Title
First Quarter Results
Announcement Reference
SG210814OTHRIG06
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
13/08/2021 00:00:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Unaudited Financial Results (Standalone and Consolidated) for the First Quarter ended June 30, 2021

Additional Details

For Financial Period Ended
30/06/2021

Attachments

BSE_NSE_FINAL RESULT - SGX.pdf
Total size =9379K